American Hospital Association Urges FTC and DOJ to Exempt Hospital Mergers from Premerger Notification Requirements Ryanair Posts Record 226 Billion Annual Profit Up 40 Despite Boeing Delivery Delays and Fuel Uncertainty SpaceX Scrubs Starship Test Flight Plans Friday Attempt as V3 Debut Approaches Food and Beverage Industry Shifts Manufacturing Investment Strategies Federal Reserve Monetary Policy Stance Under Scrutiny Amid Inflation and Growth Concerns Workday Shares Rise as AI Demand Optimism Helps Ease Investor Concerns Biofrontera BFRI Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Rises TVTX Q1 2026 Earnings EPS Miss as PreRevenue Biotech Ramps Up Spending PZG Q1 2026 Earnings EPS Misses Estimates Sharply Amid Exploration Focus MWH Q1 2026 Earnings EPS Surge of 67 Beats Estimates by Wide Margin SLVM Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Headwinds Aclarion Inc Q1 2026 Earnings EPS Surpasses Estimates as Company Prioritizes Cost Controls CEA Industries Inc BNC Holds Steady at 262 as Key Resistance Looms Banzai International Inc Warrant BNZIW Drops 12 Navigates Near Penny Territory FG Merger II Corp FGMC Holds Near 1033 as SPAC Awaits Merger Catalyst Real Asset Acquisition Corp Warrants RAAQW Drift Lower as Trading Remains Subdued Royalty Pharma RPRX Holds Ground Near Midpoint Steady Trading in Tight Range Lidl Surpasses Morrisons to Claim FifthPlace Spot in UK Grocery Market PXED Q1 2026 Earnings EPS Surges Past Estimates by 656 as BottomLine Strength Defies Broad Market Headwinds Giftify Inc GIFT Edges Higher as Shares Test Key Resistance Level McEwen Inc MUX Surges 318 as It Approaches Key Resistance Level WPP Shares Slide as Advertising Sector Faces Growth Concerns Grupo Televisa TV Edges Higher Key Levels to Watch After a Slight Rally Helix Acquisition Corp III HLXC Holds Steady Near Trust Value Amid Minimal Movement Mingteng International Corporation MTEN Rallies 79 as Stock Tests Key Resistance at 114 Nuveen Quality Municipal Income Fund NAD Gains 095 as YieldSeeking Investors Return Moleculin Biotech MBRX Holds Steady at 273 Amid Consolidation Phase